Private Equity

Permira to take UK-listed Ergomed private in £703m deal

The directors of Ergomed, who have been advised by Jefferies and Numis, said they considered the terms of the cash offer to be fair and reasonable

AIM-listed Ergomed provides services to the pharmaceutical industry and the development of new drugs across 100 countries
AIM-listed Ergomed provides services to the pharmaceutical industry and the development of new drugs across 100 countries Photo: Getty Images/Westend61

Permira has kicked off the week with a public-to-private takeover, agreeing to buy British biopharmaceutical services company Ergomed for £703.1m.

The European private equity house said on 4 September that the cash offer of 1,350p per share marks a 28% premium to Ergomed’s last closing price.

WSJ Logo
How Trump Got His ‘Big, Beautiful Bill’ Across the Finish LineExternal link

How Trump Got His ‘Big, Beautiful Bill’ Across the Finish Line